• ADAMTS13 Activity and Inhibitor Assay
  • Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Tissue
  • Brucella Antibody, IgG and IgM
  • Alpha-Galactosidase, Serum
  • Bromazepam
  • Lipoprotein Electrophoresis
  • Sphingomyelin Phosphodiesterase 1 (SMPD1) Mutation Analysis, Niemann-Pick Disease
  • Diphenhydramine, Urine
  • Angiosarcoma, MYC (8q24) Amplification, FISH, Tissue
  • Autoimmune Brain Panel (The Cunningham Panelâ„¢ for Autoimmune Neuropsychiatric Disorders)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cytochrome P450 2C19 (CYP2C19) Genotyping
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cytochrome P450 2C19 (CYP2C19) Genotyping
Medical Test

Turnaround Time
Access to Cytochrome P450 2C19 (CYP2C19) Genotyping is restricted.